CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 90,883	$ 114,916
Research and development incentive receivable	1,130	1,189
Prepaid expenses and other current assets	428	769
Total current assets	92,441	116,874
Property and equipment, net	28	36
Right-of-use assets, net	863	459
Research and development incentive receivable, net of current portion	610
Deferred tax assets	150	159
Other long term assets	60	90
Deposits	51	293
Total assets	94,203	117,911
Current liabilities:
Accounts payable	7,553	4,189
Accrued expenses	2,463	5,366
Lease liability - current portion	395	432
Total current liabilities	10,411	9,987
Non current liabilities:
Lease liability, net of current portion	474	37
Total liabilities	10,885	10,024
Stockholders' equity:
Common stock, $0.001 par value; 240,000,000 shares authorized; 88,318,454 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	88	88
Additional paid-in capital	374,108	371,638
Accumulated other comprehensive income (loss)	94	(267)
Accumulated deficit	(290,972)	(263,572)
Total stockholders' equity	83,318	107,887
Total liabilities and stockholders' equity	$ 94,203	$ 117,911